Within-host dynamics of antiviral treatment for SARS-CoV-2 infection

Lea Schuh,Peter V. Markov,Ioanna Voulgaridi,Zacharoula Bogogiannidou,Varvara A. Mouchtouri,Christos Hadjichristodoulou,Nikolaos I. Stilianakis

DOI: https://doi.org/10.1101/2024.05.31.24308284

2024-06-01

Abstract:The effectiveness of antiviral treatment with remdesivir against COVID-19 has been investigated in clinical trials suggesting earlier recovery. However, this effect seems to be rather modest. In this study, we assessed the clinical course of SARS-CoV-2 infections in 369 COVID-19 individuals across a spectrum of illness severities, including both untreated individuals and individuals who received antiviral treatment with remdesivir. Moreover, using a process-based mathematical model, we quantified and analyzed the within-host infection dynamics of 69 untreated and 19 antiviral-treated individuals. For untreated individuals, we found that those hospitalized exhibit significantly lower levels of early immune response and higher cumulative viral loads than those who were not. For treated individuals, we found that those who died were on average hospitalized later after symptom onset than those who survived, underscoring the importance of early medical intervention for severe COVID-19. Our model estimates a rather limited antiviral activity of remdesivir and, consequently, comparable viral load dynamics between individuals responding and not responding to antiviral treatment. Our results provide valuable insights into the clinical course of COVID-19 during antiviral treatment with remdesivir and suggest the need for alternative treatment regimens.

Infectious Diseases (except HIV/AIDS)

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to evaluate the effectiveness and impact of the antiviral drug remdesivir in the treatment of SARS - CoV - 2 infection. Specifically, by analyzing the data of 369 COVID - 19 patients, including those who did not receive treatment and those who received remdesivir treatment, the researchers explored the following aspects:

1. **Infection kinetics in untreated individuals**: The researchers used a process - based mathematical model to quantify and analyze the in - vivo infection kinetics of 69 untreated individuals, especially the differences between hospitalized and non - hospitalized patients.

2. **Survival rate and viral infection kinetics in treated individuals**: The researchers also used a mathematical model to analyze the viral infection kinetics of 19 individuals who received remdesivir treatment and explored the impact of treatment on survival rate.

3. **Antiviral activity of remdesivir**: The researchers estimated the antiviral activity of remdesivir and compared the viral load dynamics between individuals who responded to treatment and those who did not.

4. **The importance of early medical intervention**: The study found that treated individuals who died were usually hospitalized much later after the onset of symptoms, emphasizing the importance of early medical intervention for severe COVID - 19 patients.

5. **The impact of remdesivir on viral load dynamics**: The research results show that the antiviral effect of remdesivir is limited and fails to significantly reduce the viral load or change the viral load dynamics.

Overall, this paper aims to evaluate the efficacy of remdesivir in COVID - 19 patients with different severities through detailed mathematical models and clinical data, and to explore its impact on viral load dynamics and patient prognosis.